Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,953,260
in 5 filings, $6.0M under 10b5-1 plans

Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$6.0M Chief Executive Officer sold 41% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-26 Konstantinov Konstantin Director Grant or award · Stock Option (Right to Buy) +2,498 2,498
2022-05-26 DAWES KAREN A Director Grant or award +644 77,176
2022-05-26 DAWES KAREN A Director Grant or award · Stock Option (Right to Buy) +1,565 1,565
2022-05-26 BARTHELEMY NICOLAS Director Grant or award +534 2,081
2022-05-26 BARTHELEMY NICOLAS Director Grant or award · Stock Option (Right to Buy) +1,298 1,298
2022-05-26 MUIR GLENN P Director Grant or award +534 6,896
2022-05-26 MUIR GLENN P Director Grant or award · Stock Option (Right to Buy) +1,298 1,298
2022-05-26 EGLINTON MANNER CARRIE Director Grant or award +1,024 1,481
2022-05-26 EGLINTON MANNER CARRIE Director Grant or award · Stock Option (Right to Buy) +2,488 2,488
2022-05-25 DAWES KAREN A Director Sale −2,576 $149.18 $384K 88,671
2022-05-25 DAWES KAREN A Director Sale −7,677 $150.19 $1.2M 80,994
2022-05-25 DAWES KAREN A Director Sale −1,845 $151.14 $279K 79,149
2022-05-25 DAWES KAREN A Director Sale −1,875 $152.14 $285K 77,274
2022-05-25 DAWES KAREN A Director Sale −742 $152.84 $113K 76,532
2022-05-13 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −712 $150.40 $107K 20,110
2022-05-13 Gebski Christine See Remarks Shares withheld for taxes −335 $150.40 $50K 34,092
2022-05-13 Snodgres Jon Chief Financial Officer Shares withheld for taxes −712 $150.40 $107K 39,187
2022-04-01 Bylund James Chief Operating Officer Shares withheld for taxes −335 $188.02 $63K 9,733
2022-03-16 EGLINTON MANNER CARRIE Director Purchase +625 $175.02 $109K 2,106
2022-03-08 Snodgres Jon Chief Financial Officer Option exercise +2,952 $33.87 $100K 38,685

Page 20 of 23 · 455 trades